Call us 24/7

Neuroendocrine Tumor Clinical Program

Our program

The clinicians in the Neuroendocrine Tumor Clinical Program at Cancer Treatment Centers of America® (CTCA), Chicago, have extensive experience in diagnosing and treating neuroendocrine tumors (NETs), sometimes known as carcinoid tumors. Our doctors work with referring physicians and their patients to help treat and manage this rare disease, which develops when abnormal growths begin to form in neuroendocrine cells. NETs are staged using diagnostics including NETSPOT, an imaging agent that helps locate somatostatin receptor-positive NETs and determine treatment options. Our cancer experts then collaborate with one another, and with the patient, as part of a multidisciplinary team, to develop a personalized treatment plan tailored to each patient’s individual needs.

Our NET team brings together clinicians from multiple disciplines, all focused on caring for patients with neuroendocrine tumors.

Meet our team

Jeffery Choh, MD, Director of Interventional Radiology
Dr. Jeffrey Choh leads the Interventional Radiology program at CTCA Chicago. While caring for his patients, he uses minimally invasive techniques and some advanced interventional radiology technologies, including transarterial treatment with yttrium-90 radiation microspheres, ablative therapies and microwave technology.

Hatem Halabi, MD, FACS, Director Surgical Oncology, CTCA GI Cancer Institute
Dr. Hatem Halabi performs complex cancer surgery of the GI tract (esophagus, stomach, small bowel and colon), liver and pancreas. He also performs cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) for advanced-stage abdominal cancers and is experienced in minimally invasive, robotic surgery.

Kenny S. Yoo, MD, Interventional Radiologist
Dr. Kenny S. Yoo diagnoses and treats patients using minimally invasive and innovative techniques in order to reduce risk to patients, and improve health outcomes and quality of life. Dr. Yoo and the hospital’s interventional radiology team also use a variety of therapies, such as TheraSphere®, chemoembolization, radiofrequency ablation vertebroplasty and lutetium Lu 177 dotatate to treat cancer patients.

Revathi Suppiah, MD, Medical Oncologist
Board certified in internal medicine, hematology and medical oncology, Dr. Revathi Suppiah believes in a multidisciplinary approach to cancer care, where every member of the care team—including the patient—has input into the patient’s care plan. Dr. Suppiah treats patients diagnosed with a variety of cancers, including gastroenteropancreatic neuroendocrine tumors.

In addition to the medical professionals listed above, a trained team of nurses and nuclear medicine technologists assist throughout the continuum of care.

NET treatment options

The NET Clinical Program provides patients a comprehensive array of treatment options. The type, location and extent of the disease dictate which treatments may be available.

Treatment options may include:

  • Surgery options include minimally invasive procedures using laparoscopy or laparotomy, either to remove the entire tumor or to reduce its mass if it cannot be completely removed. Mesenteric resections for small bowel tumors and cytoreductive surgery may be recommended for advanced-stage disease.
  • Immunotherapy treatments use the drug interferon, which helps stimulate the immune system.
  • Targeted therapy drugs attack certain areas of the cancer cell or its environment (including genes and proteins) that may be responsible for the tumor’s growth.
  • Chemotherapy drugs are designed to interfere with the growth of cancer cells in order to destroy them.
  • Interventional radiology uses both catheter- and needle-based therapies.

Peptide receptor radionuclide therapy combines a cell-targeting protein (or peptide) with a radionuclide (or radioactive material), and is given intravenously to deliver a high dose of radiation to the tumors.

Because of the complexity and diversity of NETs, our experts collaborate daily, allowing them to recommend a personalized care plan.

Depending on each patient’s unique diagnosis and needs, members of the NET care team may include surgical, medical or radiation oncologists, gastroenterologists, interventional radiologists, endocrinologists, pathologists, pain management physicians, dietitians, naturopathic oncology providers, mind-body therapists and other trained clinicians.

Where we are located

CTCA Chicago

Neuroendocrine Tumor Clinical Program
2520 Elisha Ave.
Zion, IL 60099

New Patients:888-552-6760
Existing Patients:(847) 510-CTCA

Get directions